EP Wealth Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$796K Buy
8,344
+2,102
+34% +$202K ﹤0.01% 829
2026
Q1
$647K Buy
6,242
+1,600
+34% +$181K ﹤0.01% 796
2025
Q4
$468K Buy
+4,642
New +$504K ﹤0.01% 912
2025
Q2
$838K Sell
6,981
-122
-2% -$16.3K 0.01% 616
2025
Q1
$1.05M Buy
7,103
+243
+4% +$37.1K 0.01% 489
2024
Q4
$1.11M Buy
6,860
+378
+6% +$61.8K 0.01% 473
2024
Q3
$1.06M Buy
6,482
+739
+13% +$110K 0.01% 483
2024
Q2
$784K Sell
5,743
-606
-10% -$84.2K 0.01% 431
2024
Q1
$972K Sell
6,349
-461
-7% -$68.8K 0.01% 382
2023
Q4
$971K Buy
6,810
+263
+4% +$35.1K 0.01% 367
2023
Q3
$858K Sell
6,547
-36,143
-85% -$5.49M 0.01% 363
2023
Q2
$927K Buy
42,690
+3,278
+8% +$529K 0.01% 352
2023
Q1
$2.96M Buy
39,412
+33,232
+538% +$4.98M 0.05% 192
2022
Q4
$867K Buy
+6,180
New +$877K 0.02% 304
2022
Q3
Sell
-5,813
Closed -$819K 385
2022
Q2
$819K Sell
5,813
-262
-4% -$37.4K 0.02% 285
2022
Q1
$845K Sell
6,075
-173
-3% -$26.5K 0.02% 295
2021
Q4
$1.09M Sell
6,248
-2,230
-26% -$372K 0.03% 248
2021
Q3
$1.4M Buy
8,478
+1,032
+14% +$178K 0.04% 202
2021
Q2
$1.34M Buy
7,446
+11
+0.1% +$2.01K 0.04% 217
2021
Q1
$1.43M Sell
7,435
-286
-4% -$55.1K 0.05% 199
2020
Q4
$1.56M Buy
7,721
+135
+2% +$27.9K 0.05% 146
2020
Q3
$1.59M Sell
7,586
-555
-7% -$124K 0.07% 127
2020
Q2
$1.79M Sell
8,141
-567
-7% -$113K 0.08% 126
2020
Q1
$1.51M Sell
8,708
-5,597
-39% -$925K 0.07% 132
2019
Q4
$2.2M Buy
14,305
+1,225
+9% +$183K 0.09% 129
2019
Q3
$1.99M Buy
13,080
+319
+2% +$50.4K 0.1% 104
2019
Q2
$1.95M Buy
12,761
+568
+5% +$86.8K 0.12% 87
2019
Q1
$1.96M Buy
12,193
+400
+3% +$62.1K 0.19% 76
2018
Q4
$1.82M Sell
11,793
-190
-2% -$29.6K 0.14% 88
2018
Q3
$1.8M Buy
+11,983
New +$1.7M 0.14% 80

Other funds holding CLX

EP Wealth Advisors's CLX Position: Q2 2026 in Review

EP Wealth Advisors increased its Clorox (CLX) stake by 34% in Q2 2026, buying an estimated $202K and bringing the position to 8,344 shares worth $796K. The position accounts for ﹤0.01% of the portfolio, ranked #829.

EP Wealth Advisors first reported a position in CLX in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.96M in Q1 2023. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • EP Wealth Advisors held 8,344 shares of Clorox worth $796K as of Q2 2026.
  • EP Wealth Advisors bought 2,102 Clorox shares in Q2 2026, an estimated $202K.
  • Clorox made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #829 holding.
  • EP Wealth Advisors first reported a position in Clorox in Q3 2018 and has held it in 30 quarters since.
  • EP Wealth Advisors's Clorox position peaked at $2.96M in Q1 2023.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.